Grand Brilliance Group Holdings Limited
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HKSE · 8307.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 02:05 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Medicskin Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 24.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Medicskin Holdings Limited’s forward annual dividend is HK$0.04 per share, paid annual. The forward yield is 26.32% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Medicskin Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HK$0.21+HK$0.01 (+5.5%)
Republic Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 24.64% below the high.
HK$0.11+HK$0.01 (+7.92%)
Wanjia Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
HK$0.11-HK$0.01 (-5.88%)
Raily Aesthetic Medicine International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
HK$0.32HK$0.00 (0.0%)
Qianhai Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.06-HK$0.00 (-1.61%)
Elegance Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 64.12% below the high.
HK$0.02-HK$0.00 (-10.0%)
Pa Shun International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.37-HK$0.01 (-1.35%)
MaxWin International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 76.75% below the high.